Embecta Corp.

EMBC US Health Care Health Care Equipment
S&P 600
$4.94
+1.02%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of -2.28.
  • Return on capital employed is healthy at 24.1%.
  • Net profit margin is 8.8%.
  • Current assets comfortably cover current liabilities (current ratio 2.41).
  • Has paid a dividend in each of the last 4 years on record.

!Watch-points

  • Return on equity is on the lower side at -15.6%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Piotroski F-ScoreModerate
6 / 8

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 8 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$279.90M
Current Price$ 4.94
High / Low$ 15.55 / 2.77
Stock P/E3.3605442
Book Value$ -10.47
Dividend Yield9.41%
ROCE24.12%
ROE-15.57%
Debt to Equity-2.28
Current Ratio2.41
P/B Ratio-0.45681524
EPS$ 1.62
Debt$1.40B
PAT Margin8.83%
Cash PAT$136.10M
Educational data only. Not a recommendation to buy, sell or hold any security.